During the past decade, NeuroHealth, Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NeuroHealth, Inc." #1 sponsor was "Indiana University School of Medicine" with 1 trials, followed by "Institute for Neurodegenerative Disorders" with 1 trials sponsored, "Novartis" with 1 trials sponsored, "Novartis Pharmaceuticals" with 1 trials sponsored and "Teva Branded Pharmaceutical Products R&D, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NeuroHealth, Inc." #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator, "Children's Hospital Medical Center, Cincinnati" with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator, "Orion Corporation, Orion Pharma" with 1 trials as a collaborator and "The Parkinson Study Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "NeuroHealth, Inc." are "Parkinson Disease" (2 trials), "Parkinson's Disease" (2 trials), "Multiple Sclerosis" (1 trials) and "Parkinsonian Syndrome" (1 trials). Many other conditions were trialed in "NeuroHealth, Inc." in a lesser frequency.

Most popular intervention types in "NeuroHealth, Inc." are "Drug" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carbidopa/levodopa/entacapone" (1 trials), "Immediate release carbidopa/levodopa" (1 trials), "Mirapex (pramipexole)" (1 trials), "NAbs testing" (1 trials) and "[123I]ß-CIT and SPECT imaging" (1 trials). Other intervention names were less common.

The vast majority of trials in "NeuroHealth, Inc." are 5 trials for "All" genders.

Currently, there are NaN active trials in "NeuroHealth, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in NeuroHealth, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in NeuroHealth, Inc., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".